T-cell bispecific antibodies in node-positive breast cancer: novel therapeutic avenue for MHC class I loss variants
Meriem Messaoudene, Thanos Mourikis, Judith Michels, Yu Fu, Mélodie Bonvalet, M. Lacroix-Trikki, Bertrand Routy, Aurélie Fluckiger, Sylvie Rusakiewicz, María P. Roberti, Sophie Cotteret, Caroline Flament, Vichnou Poirier-Colame, Nicolas Jacquelot, François Ghiringhelli, Anne Caignard, Alexander Eggermont, Guido Guido Kroemer, Aurélien Marabelle, Mónica Arnedos, Cécile Vicier, Semih Doğan, Fanny Jaulin, Stephen‐John Sammut, Wei Cope, Carlos Caldas, Suzette Delaloge, Nicholas McGranahan, Fabrice André, Laurence Zitvogel (2019). T-cell bispecific antibodies in node-positive breast cancer: novel therapeutic avenue for MHC class I loss variants. , 30(6), DOI: https://doi.org/10.1093/annonc/mdz112.
